Items
![Default image](https://pediatrics.wustl.edu/app/plugins/washu-people-places-items//assets/images/default-items.jpg)
Cooper Lab
Megan Cooper, MD, PhD
Division of Rheumatology & Immunology
The Cooper lab is focused on mechanisms of immune cell control, including regulation of natural killer cell activation and molecular mechanisms driving pediatric immune-mediated disease.
![Default image](https://pediatrics.wustl.edu/app/plugins/washu-people-places-items//assets/images/default-items.jpg)
Critical Care Medicine
The Division of Pediatric Critical Care Medicine provides an academic structure for the activities involved in the care of critically ill children in the Washington University School of Medicine Department of Pediatrics and the St. Louis Children’s Hospital Pediatric and Cardiac Intensive Care Units.
![Critical Care Medicine](https://pediatrics.wustl.edu/app/uploads/2022/07/pccm-banner-icu0253-768x293.jpeg)
Critical Care Medicine
The Division of Pediatric Critical Care Medicine provides an academic structure for the activities involved in the care of critically ill children in the Washington University School of Medicine Department of Pediatrics and the St. Louis Children’s Hospital Pediatric and Cardiac Intensive Care Units.
![Default image](https://pediatrics.wustl.edu/app/plugins/washu-people-places-items//assets/images/default-items.jpg)
Critical Care Medicine Fellowship
Division of Pediatric Critical Care Medicine
ACGME program preparing graduates for rewarding careers in pediatric critical care medicine, supporting fellows in exploring their own areas of clinical and academic interest while establishing a solid base of foundational knowledge and experience. Program admits 5 fellows per year, and participates in the NRMP Match for pediatric critical care medicine.
![Default image](https://pediatrics.wustl.edu/app/plugins/washu-people-places-items//assets/images/default-items.jpg)
DeBosch Lab
Brian DeBosch, MD, PhD
Division of Gastroenterology, Hepatology & Nutrition
The DeBosch laboratory uses mouse genetic, physiological, cell biological and multi-omic techniques to understand the signaling pathways that are activated downstream of blocking hepatocyte glucose transporters. We found that inhibiting hepatocyte glucose transport and the adaptive responses that are engaged are sufficient to convey key aspects of the physiological response to caloric restriction. This includes upregulation of hepatic fat oxidation, autophagy and secretion of the anti-diabetic peptide — FGF21. Our goal is to understand and then utilize these responses to treat metabolic diseases, including non-alcoholic fatty liver disease, cardiovascular disease and type 2 diabetes mellitus.
![Default image](https://pediatrics.wustl.edu/app/plugins/washu-people-places-items//assets/images/default-items.jpg)
DEI Training at WashU
Offered by the Office of Diversity, Equity & Inclusion
The focus of our training is to support the School of Medicine community in developing a greater awareness, understanding, commitment and action framework regarding diversity, equity and inclusion.
![Default image](https://pediatrics.wustl.edu/app/plugins/washu-people-places-items//assets/images/default-items.jpg)
Dermatology
The pediatric dermatologists at Washington University provide comprehensive and sophisticated dermatologic care for children and adolescents. They are trained in dermatology as well as pediatrics, and have specific knowledge of the needs of children’s skin.
![Default image](https://pediatrics.wustl.edu/app/plugins/washu-people-places-items//assets/images/default-items.jpg)
Di Paola Lab
Jorge Di Paola, MD
Division of Hematology & Oncology
The Di Paola lab, headed by Jorge Di Paola, MD, comprises a diverse group of physician scientists, geneticists, bioinformaticists, and basic scientists. Advances in technology and decreases in costs of whole-genome sequencing have enabled us to pursue innovative approaches to discovering the genetic and biological determinants of a variety of conditions. We extend the scope of our research through both national and international collaboration. Using state of the art equipment and techniques, we aim to set the stage for the development of novel therapies to improve quality of life for those living with bleeding and thrombotic disorders.